Kyowa Kirin has won FDA nod for Nourianz as an add-on treatment to levodopa/carbidopa in adult Parkinson’s disease patients experiencing "off" episodes. (Pixabay/st...

AstraZeneca's Farxiga showed positive data in reducing cardiovascular risks in a new outcomes trial. (AstraZeneca) AstraZeneca is still stinging after its SGLT2 ...

(Credit: Flickr; Helge V. Keitel ) Regeneron Pharmaceuticals said its experimental drug evinacumab significantly lowered "bad" cholesterol levels 49% compared to...

(Credit: Roche ) For the third time, the Food and Drug Administration cleared a cancer drug to treat tumors based on a specific genetic signature rather than by ...

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A ph...